Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

(Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative, non-surgical therapies for urothelial and specialty cancers, today announced new post-hoc analyses from the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Anna Wenner A former pick, the Beyond XP5000 Plastic-Backed Adult Brief, has ...

Which bladder control supplements are best? Involuntary urination is a scary condition for most people, and specific medical issues, stress or aging can lead to incontinence. But there are steps you ...

Medtech giants Boston Scientific and Medtronic are doubling down on bladder-control therapies, confirming this space as one of the sector’s fastest-growing battlegrounds. Australis Scientific is ...

Anticholinergic medications block certain receptors to help control bladder contractions. Botox injections in the bladder can help when other medications have failed. Beta-3 adrenergic agonists are ...

TIFTON — Urogynecologist Judy Yeh, MD, FACOG and the Tift Regional Medical Center operating room team conducted the first Altaviva procedure in the region on Dec. 23. Approved by the FDA in September, ...